MedTrace Logo

Quality of Life After Hysterectomy (AdenoQOL)

NCT04791033 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 218

Last updated 2024-04-19

No results posted yet for this study

Summary

Adenomyosis is a disease where ectopic endometrial-like glands affect the muscular wall of the uterus. About 70% of women affected by adenomyosis suffer from dysmenorrhea and menorrhagia. A levonorgestrel-releasing intrauterine device (LNG-IUD) is the first-choice treatment of adenomyosis, but is not always sufficiently effective in all women. Those women often end up removing the uterus (hysterectomy).

Hysterectomy is clinically regarded to be an efficient and final treatment of adenomyosis, but pelvic pain may also prevail after removal of the uterus. This study aimes to investigate the short - and long-term impact of hysterectomy on quality of life (QOL) and sexual function in women with adenomyosis, and further to evaluate if there is any difference compared to women that are removing their uterus due to other benign gynecological conditions.

Conditions

  • Adenomyosis
  • Quality of Life

Interventions

PROCEDURE

Hysterectomy

Elective procedure with hysterectomy due to benign gynecological condition

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Marianne Omtvedt, MD · Oslo University Hospital

  • Tina Tellum, PhD · Oslo University Hospital

Eligibility

Min Age
18 Years
Max Age
52 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-18
Primary Completion
2022-10-30
Completion
2030-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04791033 on ClinicalTrials.gov